Sanofi
COMPOSITIONS COMPRISING IL6R ANTIBODIES FOR THE TREATMENT OF UVEITIS AND MACULAR EDEMA AND METHODS OF USING SAME
Last updated:
Abstract:
The present invention provides compositions and methods of treating and improving the symptoms of uveitis and/or macular edema using an antibody that specifically binds human interleukin-6 receptor (hIL-6R).
Status:
Application
Type:
Utility
Filling date:
24 Feb 2021
Issue date:
30 Sep 2021